Issue highlights

Welcome to the second edition of BJCP of 2021. Despite these ongoing dark times, there are reasons for renewed optimism going forward. Not least, the vaccination programme for SARS-CoV-2, work of COVAX and collaborators to ensure rapid and equitable access to COVID-19 vaccines for all countries, as well as clinical trials to find effective treatments for COVID-19. The pace of collaborative scientific progress to mitigate this pandemic is remarkable.